Application

16714264 · ANTIBODIES THAT SPECIFICALLY BIND TO HUMAN COMPLEMENT FACTOR C2b

Filed 2019-12-13 · Granted · Patent 11161900 (2021-11-02) The official file ↗The patent and its PDF ↗ · Art unit 1644 · Examiner Phillip Gambel Typical · CPC A61K 39/3955 · argenx BVBA · COOLEY LLP

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

16.8 mo

to disposition 22.7 mo

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.